Biomea Fusion (BMEA) News Today → The World’s Richest Man Blindsided by AI (From Banyan Hill Publishing) (Ad) Free BMEA Stock Alerts $12.20 +0.75 (+6.55%) (As of 01:16 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 6, 2024 | americanbankingnews.comHC Wainwright Reaffirms "Buy" Rating for Biomea Fusion (NASDAQ:BMEA)May 6, 2024 | americanbankingnews.comBiomea Fusion (NASDAQ:BMEA) Price Target Raised to $15.00May 6, 2024 | americanbankingnews.comBiomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Recommendation of "Moderate Buy" from BrokeragesMay 3, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $50.00 target price on shares of Biomea Fusion in a research report on Friday.May 3, 2024 | investorplace.comBMEA Stock Earnings: Biomea Fusion Misses EPS for Q1 2024May 2, 2024 | finance.yahoo.comBiomea Fusion Reports First Quarter 2024 Financial Results and Corporate HighlightsMay 1, 2024 | globenewswire.comBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 14, 2024 | marketbeat.comShort Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Rises By 18.2%Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 13,240,000 shares, an increase of 18.2% from the March 15th total of 11,200,000 shares. Currently, 47.8% of the company's stock are short sold. Based on an average daily trading volume, of 1,020,000 shares, the short-interest ratio is currently 13.0 days.April 11, 2024 | marketbeat.comBiomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of "Moderate Buy" by BrokeragesShares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have received an average rating of "Moderate Buy" from the eight research firms that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and six have issued a buy reApril 4, 2024 | msn.com3 Best Stocks to Buy Now, 4/4/2024, According to Top AnalystsApril 4, 2024 | marketbeat.comBiomea Fusion, Inc. to Post Q1 2024 Earnings of ($1.02) Per Share, HC Wainwright Forecasts (NASDAQ:BMEA)Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2024 earnings estimates for shares of Biomea Fusion in a report released on Monday, April 1st. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings per shareApril 3, 2024 | marketbeat.comBiomea Fusion's (BMEA) Outperform Rating Reiterated at OppenheimerOppenheimer restated an "outperform" rating and issued a $70.00 price objective on shares of Biomea Fusion in a report on Wednesday.April 3, 2024 | marketbeat.comBiomea Fusion, Inc. Forecasted to Earn Q3 2024 Earnings of ($1.06) Per Share (NASDAQ:BMEA)Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Analysts at HC Wainwright issued their Q3 2024 earnings estimates for Biomea Fusion in a report issued on Monday, April 1st. HC Wainwright analyst J. Pantginis forecasts that the company will post earnings per share of ($1.06) for the quarter. HCApril 2, 2024 | marketbeat.comBiomea Fusion's (BMEA) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.JPMorgan Chase & Co. reissued a "neutral" rating and issued a $14.00 target price (down from $51.00) on shares of Biomea Fusion in a report on Tuesday.April 2, 2024 | marketbeat.comShort Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 6.9%Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 11,200,000 shares, an increase of 6.9% from the February 29th total of 10,480,000 shares. Currently, 40.6% of the company's shares are sold short. Based on an average daily volume of 976,000 shares, the short-interest ratio is presently 11.5 days.April 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for Biomea Fusion on Promising BMF-219 Clinical Results and Strong Financial PositionApril 1, 2024 | globenewswire.comBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 1, 2024 | investorplace.comBMEA Stock Earnings: Biomea Fusion Misses EPS for Q4 2023April 1, 2024 | benzinga.comRecap: Biomea Fusion Q4 EarningsApril 1, 2024 | globenewswire.comBiomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219April 1, 2024 | globenewswire.comBiomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsMarch 21, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Trading 7.2% Higher Biomea Fusion (NASDAQ:BMEA) Trading Up 7.2%March 18, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Trading Down 5.9%Biomea Fusion (NASDAQ:BMEA) Stock Price Down 5.9%March 17, 2024 | finance.yahoo.comBMEA Apr 2024 5.000 putMarch 17, 2024 | finance.yahoo.comBMEA Apr 2024 5.000 callMarch 16, 2024 | marketbeat.comShort Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Drops By 11.0%Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the target of a large drop in short interest in the month of February. As of February 29th, there was short interest totalling 10,480,000 shares, a drop of 11.0% from the February 14th total of 11,780,000 shares. Based on an average daily trading volume, of 1,250,000 shares, the days-to-cover ratio is currently 8.4 days. Currently, 38.0% of the company's shares are sold short.March 13, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Trading 6.7% Higher Biomea Fusion (NASDAQ:BMEA) Trading 6.7% HigherMarch 13, 2024 | marketbeat.comBiomea Fusion Target of Unusually High Options Trading (NASDAQ:BMEA)Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock investors bought 32,261 call options on the stock. This is an increase of 903% compared to the average daily volume of 3,217 call options.March 12, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Raises Position in Biomea Fusion, Inc. (NASDAQ:BMEA)Adage Capital Partners GP L.L.C. raised its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 125.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 180,000 shares of the company's stockMarch 7, 2024 | investorplace.com7 Short-Squeeze Stocks That Could Send the Bears Into Panic-ModeMarch 7, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Biomea Fusion (BMEA) and Jasper Therapeutics (JSPR)March 6, 2024 | markets.businessinsider.comBuy Rating Affirmed for Biomea Fusion on Promising BMF-219 Clinical Trial Outcomes and Strong Safety ProfileMarch 6, 2024 | finance.yahoo.comBiomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219’s 28-Day Treatment Cycle, Supporting Improved Pancreatic FunctionMarch 6, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Shares Gap Down to $17.52Biomea Fusion (NASDAQ:BMEA) Shares Gap Down to $17.52March 6, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Receives Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $50.00 price target on shares of Biomea Fusion in a report on Wednesday.March 6, 2024 | globenewswire.comBiomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219's 28-Day Treatment Cycle, Supporting Improved Pancreatic FunctionMarch 3, 2024 | marketbeat.comBiomea Fusion, Inc. (NASDAQ:BMEA) Short Interest UpdateBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 11,780,000 shares, an increase of 19.0% from the January 31st total of 9,900,000 shares. Currently, 42.7% of the company's shares are sold short. Based on an average trading volume of 1,370,000 shares, the days-to-cover ratio is presently 8.6 days.March 1, 2024 | markets.businessinsider.comBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 1, 2024 | globenewswire.comBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)February 29, 2024 | marketbeat.comFmr LLC Has $73.54 Million Stock Holdings in Biomea Fusion, Inc. (NASDAQ:BMEA)Fmr LLC grew its stake in Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 0.6% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,344,191 shares of the company's stock after purchasing an additFebruary 27, 2024 | seekingalpha.comWhy Biomea Fusion Is A 'Hold': A Bet On Diabetes And Oncology ResearchFebruary 26, 2024 | marketbeat.comCitigroup Inc. Buys 61,810 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA)Citigroup Inc. lifted its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 113.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 116,134 shares of the company's stock after buying an aFebruary 21, 2024 | marketbeat.comRafferty Asset Management LLC Raises Stock Holdings in Biomea Fusion, Inc. (NASDAQ:BMEA)Rafferty Asset Management LLC grew its position in Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 70.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 233,848 shares of the company's stock after bFebruary 19, 2024 | markets.businessinsider.comFeeling Shut Out? 3 Sizzling Stocks and the Pull-Back Prices to Watch ForFebruary 18, 2024 | investorplace.com3 Speculative Stocks That Could Make Your February UnforgettableFebruary 17, 2024 | marketbeat.comBarclays PLC Acquires 49,485 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA)Barclays PLC grew its holdings in Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 73.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 116,621 shares of the company's stock after buying an additional 49,4February 12, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Shares Down 1.9% Biomea Fusion (NASDAQ:BMEA) Shares Down 1.9%February 9, 2024 | marketbeat.comJump Financial LLC Lowers Stake in Biomea Fusion, Inc. (NASDAQ:BMEA)Jump Financial LLC trimmed its position in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 55.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 42,716 shares of the company's stock after selling 52,857 sharFebruary 7, 2024 | markets.businessinsider.comDissecting My Biomea Fusion (NASDAQ:BMEA) Options Trade: Tips, Tricks, and Lessons LearnedFebruary 6, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Shares Gap Up to $18.60Biomea Fusion (NASDAQ:BMEA) Shares Gap Up to $18.60 Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address The World’s Richest Man Blindsided by AI (Ad)These billionaires know that early investors in AI stand to make a lot of money. The same is true for everyday Americans... including you. Get the full story here. BMEA Media Mentions By Week BMEA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMEA News Sentiment▼1.180.57▲Average Medical News Sentiment BMEA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMEA Articles This Week▼22▲BMEA Articles Average Week Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANNX News HRTX News KRRO News MRSN News LXRX News NGNE News CRBP News ESPR News PEPG News RVNC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMEA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomea Fusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
